downwardsfromzero wrote:It would appear that they extrapolate their findings with 5-MeO-DMT across to the perceived benefits of ayahuasca which is not a valid thing to do, and right from the start they appear to conflate DMT and 5-MeO-DMT when really a clear distinction should be made. I suspect a decent peer review should clear that up.
I think the authors may actually be referring to dimethyltryptamines as a family of compounds, and stating that they are present in ayahuasca, virola snuff, and other entheogens used by Amerindian tribes. Was this the passage you were referring to?
Quote:Dimethyltryptamines are hallucinogenic serotonin-like molecules present in
traditional Amerindian medicine (e.g. Ayahuasca, Virola) recently associated
with cognitive gains, antidepressant effects and changes in brain areas
related to attention, self-referential thought, and internal mentation.
My guess is that the line below is a typo and should read
dimethyltriptamines:
Quote:Here we used shotgun mass spectrometry to
explore proteomic differences induced by dimethyltryptamine (5-methoxy-N,N
dimethyltryptamine, 5-MeO-DMT) on human cerebral organoids.
I could be wrong, but I noticed other basic syntactical errors that could easily be a result of translation from Portuguese to English.